Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Etoposide phosphate disodium

😃Good
Catalog No. T38607Cas No. 122405-33-8
Alias Etoposide phosphate disodium, BMY-40481 disodium

Etoposide phosphate disodium (BMY-40481 disodium), a phosphate ester prodrug of etoposide, is a potent chemotherapeutic agent that selectively inhibits topoisomerase II, hindering the re-ligation of DNA strands. Regarded as the active equivalent of etoposide, it effectively induces cell cycle arrest, apoptosis, and autophagy in cancer cells.

Etoposide phosphate disodium

Etoposide phosphate disodium

😃Good
Catalog No. T38607Alias Etoposide phosphate disodium, BMY-40481 disodiumCas No. 122405-33-8
Etoposide phosphate disodium (BMY-40481 disodium), a phosphate ester prodrug of etoposide, is a potent chemotherapeutic agent that selectively inhibits topoisomerase II, hindering the re-ligation of DNA strands. Regarded as the active equivalent of etoposide, it effectively induces cell cycle arrest, apoptosis, and autophagy in cancer cells.
Pack SizePriceAvailabilityQuantity
5 mg$970Backorder
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Etoposide phosphate disodium (BMY-40481 disodium), a phosphate ester prodrug of etoposide, is a potent chemotherapeutic agent that selectively inhibits topoisomerase II, hindering the re-ligation of DNA strands. Regarded as the active equivalent of etoposide, it effectively induces cell cycle arrest, apoptosis, and autophagy in cancer cells.
In vitro
Etoposide phosphate disodium, a water-soluble derivative and likely prodrug of etoposide, is distinguished by a phosphate group at position 4' on the E ring of the etoposide molecule[1]. It demonstrates dose-dependent inhibition of HCT116 FBXW7 +/+, FBXW7 -/-, and p53 -/- cells, with IC50 values being 0.945 μM, 0.375 μM, and 1.437 μM respectively, when administered at concentrations ranging from 0-1 μM over 72 hours[2]. At a concentration of 25 μM for 6 hours, etoposide phosphate disodium delays the recovery of p53 in cells deficient in FBXW7, where FBXW7 expression is absent in FBXW7 -/- cells[2]. Cell viability assays show that the compound inhibits the growth of HCT116 FBXW7 +/+, FBXW7 -/-, and p53 -/- cells in a concentration-dependent manner at varying concentrations up to 1 μM over 72 hours[2]. Additionally, Western Blot analysis reveals that at 25 μM concentration for 6 hours, there is a delayed recovery of p53 levels in HCT116 FBXW7 +/+ or FBXW7 -/- cells post DNA damage, mediated by FBXW7 presence[2].
In vivo
Etoposide phosphate, administered as a single intravenous injection at dosages of 50, 100, or 150 mg/kg, induces prominent clinical symptoms in female CD-1 mice, including progressive ataxia, an impaired righting reflex, and splaying coupled with paresis of both fore- and hindlimbs by day 8. Similarly observed under light microscopy (LM) were degenerative changes in dorsal root ganglion cells and axonal degeneration in their distal and proximal processes affecting peripheral nerves, dorsal spinal roots, and dorsal funiculi of the spinal cord across all tested doses.
AliasEtoposide phosphate disodium, BMY-40481 disodium
Chemical Properties
Molecular Weight712.5
FormulaC29H31Na2O16P
Cas No.122405-33-8
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Etoposide phosphate disodium | purchase Etoposide phosphate disodium | Etoposide phosphate disodium cost | order Etoposide phosphate disodium | Etoposide phosphate disodium chemical structure | Etoposide phosphate disodium in vivo | Etoposide phosphate disodium in vitro | Etoposide phosphate disodium formula | Etoposide phosphate disodium molecular weight